2Daleno C,Piralla A,Usonis V,et al.Novel human enterovirus C infection in child with community-acquired Pneumonia[J].Emerg Infect Dis,2012,18(11):1913-1915.
6MAR M,FELIX G,CONRADO S,et al.Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index[J].Chest,2005,128(4):2223-2229.
7KRUGER S,EWIG S,MARRE R,et al.Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes[J].Eur Respir J,2008,31(2):349-355.
8HUANG D,WEISSFELD L,KELLUM J,et al.Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia[J].Ann Emerg Med,2008,52(1):48-58,.
9SCHUETZ P,BATSCHWAROFF M,DUSEMUND F,et al.Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions:a post-study survey[J].Eur J Clin Microbiol Infect Dis,2010,29(3):269-277.
10CHRIST M,JACCARD D,BINQISSER R,et al.Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:cluster-randomised,single-blinded intervention trial[J].Lancet,2004,363(9409):600-607.
